Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21848495 | 0.99 | ELANE (0.32) | ELANECNR2GABRA1GABRG2GABRB3 | |
| SCHEMBL21848498 | 0.93 | L3MBTL1 (0.33) | ELANECNR2GABRA1GABRG2GABRB3 | |
| SCHEMBL15625163 | 0.79 | NLRP3 (0.35) | ELANECNR2L3MBTL1NLRP3 | |
| SCHEMBL21133956 | 0.75 | — | — | |
| SCHEMBL21848494 | 0.73 | — | — | |
| SCHEMBL21133952 | 0.71 | CYP1A2 (0.31) | CYP2C9 | |
| SCHEMBL12938934 | 0.71 | LMNA (0.43) | ELANEL3MBTL1 | |
| SCHEMBL21848497 | 0.70 | MIF (0.30) | ELANE | |
| SCHEMBL16317719 | 0.69 | DGAT1 (0.34) | — | |
| SCHEMBL15934881 | 0.69 | ELANE (0.42) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11217435-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2022-01-04 | — | — | US | disclosed |
| US-20200090917-A1 | TUNED SYNTHETIC DENDRIMER CALIBRANTS FOR MASS SPECTROMETRY | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2020-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11217435-B2 | Tuned synthetic dendrimer calibrants for mass spectrometry | SRMS, SRM, DNMT1 | ELANE 2209/4885CNR2 3209/4885GABRA1 795/4885 |
| US-20200090917-A1 | TUNED SYNTHETIC DENDRIMER CALIBRANTS FOR MASS SPECTROMETRY | SRMS, SRM, DNMT1 | ELANE 2209/4885CNR2 3209/4885GABRA1 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.